Difficulty: Medium
Average Score: 70%
Practice
A patient who has been taking an oral antihypertensive drug for about a year develops a positive Coombs' test. Which of the following drugs is the most likely cause?
Correct answer
D
Rationale
The correct answer is D) Methyldopa. Methyldopa is known to cause a positive Coombs' test, indicating hemolytic anemia as a potential side effect. Methyldopa is a prodrug that is metabolized to form a reactive metabolite that can bind to red blood cells, leading to antibody formation and subsequent hemolysis. This adverse effect is unique to Methyldopa among the listed antihypertensive drugs.
Option A) Captopril is an ACE inhibitor and is not associated with causing a positive Coombs' test. Option B) Clonidine is an alpha-2 adrenergic agonist and does not typically lead to a positive Coombs' test. Option C) Labetalol is a combined alpha and beta blocker and is not commonly linked to hemolytic anemia or a positive Coombs' test.
Educationally, understanding the potential side effects of medications used in managing cardiovascular conditions is crucial for healthcare professionals. Recognizing adverse reactions like a positive Coombs' test can prompt timely intervention and prevent further complications in patients. It highlights the importance of monitoring and assessing patients regularly for both intended therapeutic effects and potential adverse drug reactions.
Option A) Captopril is an ACE inhibitor and is not associated with causing a positive Coombs' test. Option B) Clonidine is an alpha-2 adrenergic agonist and does not typically lead to a positive Coombs' test. Option C) Labetalol is a combined alpha and beta blocker and is not commonly linked to hemolytic anemia or a positive Coombs' test.
Educationally, understanding the potential side effects of medications used in managing cardiovascular conditions is crucial for healthcare professionals. Recognizing adverse reactions like a positive Coombs' test can prompt timely intervention and prevent further complications in patients. It highlights the importance of monitoring and assessing patients regularly for both intended therapeutic effects and potential adverse drug reactions.